4.7 Article

Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 225, Issue 8, Pages 1415-1423

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiaa434

Keywords

impact evaluation; malaria; mass drug administration; routine data

Funding

  1. Bill & Melinda Gates Foundation [OPP1134518]
  2. Bill and Melinda Gates Foundation [OPP1134518] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

This study found that implementing 1 year of programmatic mass drug administration in southern Zambia significantly reduced malaria incidence. However, additional tools and measures are needed for malaria elimination.
This study evaluated 1 year of programmatic mass drug administration (pMDA) on malaria incidence in southern Zambia and found that areas where pMDA was conducted saw a 46% greater decrease in incidence at the time of intervention than comparison areas. Background In 2016, the Zambian National Malaria Elimination Centre started programmatic mass drug administration (pMDA) campaigns with dihydroartemisinin-piperaquine as a malaria elimination tool in Southern Province. Two rounds were administered, 2 months apart (coverage 70% and 57%, respectively). We evaluated the impact of 1 year of pMDA on malaria incidence using routine data. Methods We conducted an interrupted time series with comparison group analysis on monthly incidence data collected at the health facility catchment area (HFCA) level, with a negative binomial model using generalized estimating equations. Programmatic mass drug administration was conducted in HFCAs with greater than 50 cases/1000 people per year. Ten HFCAs with incidence rates marginally above this threshold (pMDA group) were compared with 20 HFCAs marginally below (comparison group). Results The pMDA HFCAs saw a 46% greater decrease in incidence at the time of intervention than the comparison areas (incidence rate ratio = 0.536; confidence interval = 0.337-0.852); however, incidence increased toward the end of the season. No HFCAs saw a transmission interruption. Conclusions Programmatic mass drug administration, implemented during 1 year with imperfect coverage in low transmission areas with suboptimal vector control coverage, significantly reduced incidence. However, elimination will require additional tools. Routine data are important resources for programmatic impact evaluations and should be considered for future analyses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available